236 related articles for article (PubMed ID: 26808367)
21. Characteristics and outcomes of children with acute myeloid leukemia and Down syndrome who are ineligible for clinical trials due to severe comorbidities.
Nakashima K; Hasegawa D; Tomizawa D; Miyamura T; Hama A; Iwamoto S; Terui K; Adachi S; Taga T
Pediatr Blood Cancer; 2019 Nov; 66(11):e27942. PubMed ID: 31423753
[TBL] [Abstract][Full Text] [Related]
22. Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome.
Zwaan CM; Kaspers GJ; Pieters R; Hählen K; Janka-Schaub GE; van Zantwijk CH; Huismans DR; de Vries E; Rots MG; Peters GJ; Jansen G; Creutzig U; Veerman AJ
Blood; 2002 Jan; 99(1):245-51. PubMed ID: 11756178
[TBL] [Abstract][Full Text] [Related]
23. Outcome of acute lymphoblastic leukemia in children with down syndrome-Polish pediatric leukemia and lymphoma study group report.
Zawitkowska J; Odój T; Drabko K; Zaucha-Prażmo A; Rudnicka J; Romiszewski M; Matysiak M; Kwiecińska K; Ćwiklińska M; Balwierz W; Owoc-Lempach J; Derwich K; Wachowiak J; Niedźwiecki M; Adamkiewicz-Drożyńska E; Trelińska J; Młynarski W; Kołtan A; Wysocki M; Tomaszewska R; Szczepański T; Płonowski M; Krawczuk-Rybak M; Ociepa T; Urasiński T; Mizia-Malarz A; Sobol-Milejska G; Karolczyk G; Kowalczyk J
Pediatr Hematol Oncol; 2017 May; 34(4):199-205. PubMed ID: 29040012
[TBL] [Abstract][Full Text] [Related]
24. Development of acute lymphoblastic leukemia following treatment for acute myeloid leukemia in children with Down syndrome: A case report and retrospective review of Children's Oncology Group acute myeloid leukemia trials.
Murphy BR; Roth M; Kolb EA; Alonzo T; Gerbing R; Wells RJ
Pediatr Blood Cancer; 2019 Aug; 66(8):e27700. PubMed ID: 30908863
[TBL] [Abstract][Full Text] [Related]
25. Maternal health conditions during pregnancy and acute leukemia in children with Down syndrome: A Children's Oncology Group study.
Ognjanovic S; Puumala S; Spector LG; Smith FO; Robison LL; Olshan AF; Ross JA
Pediatr Blood Cancer; 2009 May; 52(5):602-8. PubMed ID: 19148952
[TBL] [Abstract][Full Text] [Related]
26. Reproductive history, infertility treatment, and the risk of acute leukemia in children with down syndrome: a report from the Children's Oncology Group.
Puumala SE; Ross JA; Olshan AF; Robison LL; Smith FO; Spector LG
Cancer; 2007 Nov; 110(9):2067-74. PubMed ID: 17849462
[TBL] [Abstract][Full Text] [Related]
27. Child and maternal household chemical exposure and the risk of acute leukemia in children with Down's syndrome: a report from the Children's Oncology Group.
Alderton LE; Spector LG; Blair CK; Roesler M; Olshan AF; Robison LL; Ross JA
Am J Epidemiol; 2006 Aug; 164(3):212-21. PubMed ID: 16760223
[TBL] [Abstract][Full Text] [Related]
28. Health-related Quality of Life (HR-QOL) and Chronic Health Conditions in Survivors of Childhood Acute Myeloid Leukemia (AML) with Down Syndrome (DS): A Report From the Children's Oncology Group.
Schultz KA; Chen L; Kunin-Batson A; Chen Z; Woods WG; Gamis A; Kawashima T; Oeffinger KC; Nicholson HS; Neglia JP
J Pediatr Hematol Oncol; 2017 Jan; 39(1):20-25. PubMed ID: 27906794
[TBL] [Abstract][Full Text] [Related]
29. Acute leukemias in children with Down syndrome.
Zwaan CM; Reinhardt D; Hitzler J; Vyas P
Hematol Oncol Clin North Am; 2010 Feb; 24(1):19-34. PubMed ID: 20113894
[TBL] [Abstract][Full Text] [Related]
30. MTHFR 677C-->T and 1298A-->C polymorphisms in children with Down syndrome and acute myeloid leukemia in Brazil.
Amorim MR; Zanrosso CW; Magalhães IQ; Pereira SC; Figueiredo A; Emerenciano M; Pinheiro VR; d'Andréa ML; Orioli IM; Koifman S; Pombo-de-Oliveira MS
Pediatr Hematol Oncol; 2008 Dec; 25(8):744-50. PubMed ID: 19065440
[TBL] [Abstract][Full Text] [Related]
31. Leukemia and lymphoma incidence in children in Alberta, Canada: a population-based 22-year retrospective study.
Kulkarni K; Stobart K; Witol A; Rosychuk RJ
Pediatr Hematol Oncol; 2011 Nov; 28(8):649-60. PubMed ID: 21981741
[TBL] [Abstract][Full Text] [Related]
32. Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.
Gamis AS; Woods WG; Alonzo TA; Buxton A; Lange B; Barnard DR; Gold S; Smith FO;
J Clin Oncol; 2003 Sep; 21(18):3415-22. PubMed ID: 12885836
[TBL] [Abstract][Full Text] [Related]
33. Unique clinical and biological features of leukemia in Down syndrome children.
Xavier AC; Ge Y; Taub J
Expert Rev Hematol; 2010 Apr; 3(2):175-86. PubMed ID: 21083461
[TBL] [Abstract][Full Text] [Related]
34. Parental age, family size, and offspring's risk of childhood and adult acute leukemia.
Larfors G; Hallböök H; Simonsson B
Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1185-90. PubMed ID: 22539609
[TBL] [Abstract][Full Text] [Related]
35. Hematological disorders and leukemia in children with Down syndrome.
Bruwier A; Chantrain CF
Eur J Pediatr; 2012 Sep; 171(9):1301-7. PubMed ID: 22113227
[TBL] [Abstract][Full Text] [Related]
36. Acute lymphoblastic leukemia in patients with Down syndrome with a previous history of acute myeloid leukemia.
Tomizawa D; Endo A; Kajiwara M; Sakaguchi H; Matsumoto K; Kaneda M; Taga T
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28012245
[TBL] [Abstract][Full Text] [Related]
37. Acute leukemias in children with Down syndrome.
Seewald L; Taub JW; Maloney KW; McCabe ER
Mol Genet Metab; 2012 Sep; 107(1-2):25-30. PubMed ID: 22867885
[TBL] [Abstract][Full Text] [Related]
38. Acute leukemia in children with Down's syndrome: the importance of population based study.
James R; Lightfoot T; Simpson J; Moorman AV; Roman E; Kinsey S;
Haematologica; 2008 Aug; 93(8):1262-3. PubMed ID: 18519512
[No Abstract] [Full Text] [Related]
39. Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome.
Meyr F; Escherich G; Mann G; Klingebiel T; Kulozik A; Rossig C; Schrappe M; Henze G; von Stackelberg A; Hitzler J
Br J Haematol; 2013 Jul; 162(1):98-106. PubMed ID: 23594030
[TBL] [Abstract][Full Text] [Related]
40. Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952.
Bassal M; La MK; Whitlock JA; Sather HN; Heerema NA; Gaynon PS; Stork LC
Pediatr Blood Cancer; 2005 Jan; 44(1):21-8. PubMed ID: 15368546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
